ALAB
Astera Labs, Inc.Close $287.48EOD onlyThis page reflects ALAB options positioning from the latest published market-close snapshot. Intraday price and contract changes are not displayed.
Historical consensus-supported lens with full content, report chain context, and metric rail.
Outlook
Bearish with a near-term pin risk to $110. Confidence: 6/10. Spot is below max pain ($122) and GEX is negative, supporting a trending regime. However, the massive $80 put OI wall creates a structural floor, and the market is pricing in extreme volatility (IV 88.8%). The primary conflict is between the near-term pin gravity at $110 and the longer-term bearish drift in max pain.
Conflicts: Massive $80 put OI wall (6,969) creates a distant floor, IV >85% implies premium selling edge.
Regime Classification
Price Range Forecast
Key Levels
Dealer Positioning (GEX/DEX)
GEX: $-5.2M
DEX: +6.8M shares
Gamma flip: ~$80 (Approx — based on put OI concentration of 6,969)
NTM gamma: Dealer long gamma is concentrated far OTM at ~$80. Near spot, gamma is negative, meaning **dealers hedge by selling into rallies and buying into dips**, amplifying moves. A +2% move to ~$112 increases negative gamma pressure; a -2% move to ~$107 does the same.
IV Analysis
IV vs VIX: IV 88.8% is extreme, indicating high single-stock risk. This is rich versus any broad market measure, offering strong edge to premium sellers.
Term structure: **Upward sloping (backwardation)** from 63.1% (2d) to 87.8% (45d), then flat. This kink shows extreme near-term event risk decaying quickly. The 5/08 expiry (87.4%) is peak IV, likely pricing the 5/05 earnings.
Skew: The steep near-term term structure (2d IV 63.1% vs 10d IV 71.6%) supports **calendar spreads selling the front week and buying a later expiry** to capture vol decay.
Flow Analysis
Net premium: -$25.7M bearish; P/C vol 1.16, P/C OI 0.90.
Directional prints: **$105P (4/10) vol 227 vs OI 4,364** — could be opening protective puts or closing. **$110C (4/10) vol 114 vs OI 2,342** — could be call selling or closing. Flow is mixed, consistent with regime.
Unusual: **$200C (8/21) vol 249 vs OI 148 (1.7x) at IV 83.9%** — likely a low-probability, high-conviction upside bet or a volatility purchase.
Risks & Catalysts
Strategy Viability
| Strategy | Edge | Best Setup | Primary Risk |
|---|---|---|---|
| Long stock | Moderate-Weak | N/A | Negative GEX and falling MP trend oppose directional longs; better to finance with premium. |
| Short stock | Moderate | N/A | Aligns with regime but faces strong near-term pin to $110 and extreme IV makes borrow cost high. |
| Covered call | Moderate-Strong | Own stock, sell $115C or $120C (4/17 or 4/24) | Stock drifts lower; call premium high but caps upside. |
| Cash-secured put / put spread | Strong | Sell $100/$95 put spread (4/17). Use $100 (support) and $95 (2w EM low). | Break below $95. |
| Long calls | Weak | N/A | Buying premium in high IV, negative gamma regime is low-probability. |
| Long puts / bear put spread | Moderate | Buy $105/$100 put spread (4/17). Targets move to 1w EM low. | High IV and near-term pin create headwinds; defined risk preferred. |
| Iron condor | Moderate-Weak | N/A | GEX negative; VIX equivalent >25. Trending regime unfavorable for range-bound shorts. |
| Calendar/diagonal | Moderate-Strong | **Reverse Calendar**: Sell $110C (4/10, IV 71.6%), Buy $110C (5/08, IV 87.4%). | Directional move through short strike. |
| PMCC / LEAPS diagonal | Moderate | Buy $80 LEAPS (1/27), sell $115C (4/17) against it. Leverages structural put wall. | Capital intensive; time decay on long leg if stock stagnates. |
Top Plays
Watchlist Triggers
Tactical Summary
Each report translates the same market-close options snapshot into a specific lens such as directional bias, premium-selling posture, flow quality, or earnings setup.
Reports are most useful for narrowing the playbook, surfacing entry and risk context, and deciding which raw data page to inspect next.
These are interpretation layers, not execution guarantees. Validate the setup against chain liquidity, expected move, and exposure before sizing risk.